Sign In
Buy MIR
$18.24
+0.200 (+1.11%)
At Close: Jun 03, 2026
Mirion Technologies Announces Earnings Release and Conference Call Date for Second Quarter 2022
08:00am, Friday, 15'th Jul 2022
ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (NYSE: MIR) (“Mirion”) (“Company”) announced today that it will release its financial results for the second quarter of 2022 on Friday, July
MedMira Strengthens and Expands Board
11:00pm, Thursday, 14'th Jul 2022 GlobeNewswire Inc.
HALIFAX, Nova Scotia, July 14, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the appointment of Ms. Pascale Nini to the Board of Directors. In addition, Mr. Thomas Ber
MedMira Reports Third Quarter Results FY2022
02:00am, Thursday, 30'th Jun 2022 GlobeNewswire Inc.
HALIFAX, Nova Scotia, June 29, 2022 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended April 30, 2022.
Mirion Technologies to Present at CJS Securities' 22nd Annual “New Ideas” Summer Conference
04:15pm, Wednesday, 29'th Jun 2022
ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at CJS Securities'
MedMira Receives Patent for its Unique Quantitative Diagnostic System
11:48am, Monday, 06'th Jun 2022 GlobeNewswire Inc.
HALIFAX, Nova Scotia, June 06, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a U.S. patent (number 11,353,450) for their new innovative and quantitativ
MedMira provides an update on the new In Vitro Diagnostic Medical Devices Regulation (IVDR) in the European Market
12:01pm, Friday, 27'th May 2022 GlobeNewswire Inc.
HALIFAX, Nova Scotia, May 27, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on its regulatory progress in Europe and any market accepting the CE mark. MedMira
VYRA™ Product Line Update
12:52pm, Friday, 20'th May 2022 GlobeNewswire Inc.
HALIFAX, Nova Scotia, May 20, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on the Company’s regulatory work for Canada for its VYRA™ product line. On th
MedMira receives CE mark for Multiplo® Complete Syphilis (TP/nTP) Antibody Test
12:40pm, Thursday, 12'th May 2022 GlobeNewswire Inc.
HALIFAX, Nova Scotia, May 12, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the achievement of another milestone in its regulatory strategy by receiving the CE mark fo
Mirion Technologies, Inc. (MIR) CEO Tom Logan on Q1 2022 Results - Earnings Call Transcript
03:55pm, Wednesday, 04'th May 2022
Mirion Technologies, Inc. (NYSE:MIR ) Q1 2022 Earnings Conference Call May 4, 2022 11:00 AM ET Company Participants Alex Gaddy - Vice President, Finance and Investor Relations Larry Kingsley - Chairma
Mirion Technologies to Present at Goldman Sachs' Industrials and Materials Conference
08:45am, Wednesday, 27'th Apr 2022
ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Goldman Sachs'
Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2022
02:04pm, Thursday, 24'th Mar 2022 Benzinga
Upgrades
For iRobot Corp (NASDAQ:IRBT), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform. In the fourth quarter, iRobot showed an EPS of $1.05, compared to $0.84
MedMira receives the CE mark for its Reveal® TP (Syphilis) and starts clinical trials in Canada
01:17pm, Wednesday, 09'th Mar 2022 GlobeNewswire Inc.
HALIFAX, Nova Scotia, March 09, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) launches its Reveal® TP (Syphilis) product in Europe and gets clinical trials underway in Canada.
Mirion Technologies, Inc. (MIR) CEO Tom Logan on Q4 2021 Results - Earnings Call Transcript
01:41pm, Wednesday, 23'rd Feb 2022
Mirion Technologies, Inc. (MIR) CEO Tom Logan on Q4 2021 Results - Earnings Call Transcript
MedMira Receives CE Marking for its REVEALCOVID-19® PLUS Total Antibody Test
02:00am, Wednesday, 09'th Feb 2022 GlobeNewswire Inc.
HALIFAX, Nova Scotia, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) has received the CE mark for its REVEALCOVID-19® PLUS Total Antibody Test. The test will be availab
MedMira Provides a Pre-Annual General Meeting Update
12:17pm, Friday, 04'th Feb 2022 GlobeNewswire Inc.
HALIFAX, Nova Scotia, Feb. 04, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) provides a pre-Annual General Meeting (AGM) update on its regulatory and product development progres
